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Y Chromosome, Mitochondrial 
DNA and Childhood Behavioural 
Traits
Laurence J. Howe1, A. Mesut Erzurumluoglu  1,2, George Davey Smith1, Santiago Rodriguez1 
& Evie Stergiakouli1
Many psychiatric traits are sexually dimorphic in terms of prevalence, age of onset, progression and 
prognosis; sex chromosomes could play a role in these differences. In this study we evaluated the 
association between Y chromosome and mitochondrial DNA haplogroups with sexually-dimorphic 
behavioural and psychiatric traits. The study sample included 4,211 males and 4,009 females with 
mitochondrial DNA haplogroups and 4,788 males with Y chromosome haplogroups who are part 
of the Avon Longitudinal Study of Parents and Children (ALSPAC) based in the United Kingdom. 
Different subsets of these populations were assessed using measures of behavioural and psychiatric 
traits with logistic regression being used to measure the association between haplogroups and the 
traits. The majority of behavioural traits in our cohort differed between males and females; however 
Y chromosome and mitochondrial DNA haplogroups were not associated with any of the variables. 
These findings suggest that if there is common variation on the Y chromosome and mitochondrial DNA 
associated with behavioural and psychiatric trait variation, it has a small effect.
Childhood psychiatric disorders are amongst the best examples of sexual dimorphism in disease. Males and 
females differ in terms of prevalence, age of onset, development and prognosis of psychiatric disorders1; both 
ADHD and autism are thought to be more prevalent in males2, 3 while psychosis is thought to have an earlier 
age of onset in men compared to women4. Several theories have been proposed to explain sex differences in psy-
chiatric traits such as the “male brain hypothesis”5 and “imprinting of the brain”6 however research on possible 
contributing factors is largely limited7. Many childhood psychiatric disorders, including ADHD and autism, can 
be conceptualized as extremes of continuous traits found in the general population with the same risk factors con-
tributing to both clinical disease and subclinical traits8–10. One of the genetic factors that clearly differs between 
males and females is the sex chromosome complement. Some Y chromosome genes are expressed in the human 
brain11 and the Y chromosome has been associated with increased aggression and impaired parental behaviour in 
animal models where the sex chromosome complement has been dissociated from the hormonal milieu12. There 
is mixed evidence over whether patients with sex chromosome abnormalities are at increased risk of psychiatric 
disorders, varying by abnormality and disorder13–15.
Despite its potential involvement in sexually dimorphic disorders and traits, the Y chromosome, which is the 
sex-determining chromosome in humans, is largely excluded from genetic studies even of sexually dimorphic 
disease. The Y chromosome is passed largely unchanged from father to son and consists of the non-recombining 
region (NRY) and small pseudoautosomal regions at the telomeres. The lack of recombination provides the Y 
chromosome with the best haplotypic resolution in the human genome. However, the implication of lack of 
recombination is that the Y chromosome cannot be studied easily as part of a genome-wide association study 
(GWAS) pipeline. In contrast, it is analysed using haplogroups which are stable lineages of the Y chromosomes 
that share a common ancestor. The Y Chromosome Consortium (YCC) has produced a nomenclature system 
incorporating all verified Y chromosome single nucleotide polymorphisms (SNPs) and defining Y chromosome 
haplogroups16.
Mitochondrial DNA is separate from nuclear DNA and is contained within mitochondria; intracellular orga-
nelles that provide energy to the cell. Its inheritance is analogous to the Y chromosome with DNA inherited 
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unchanged, apart from mutations, from the mother. As for the Y chromosome, haplogroups are used to study 
its association with disease meaning that mitochondrial DNA is often omitted from GWAS17. Mutations of 
mitochondrial DNA can cause neuromuscular disorders which affect around 1 in 5000 individuals18. Increased 
co-morbidity has been reported between these disorders and psychiatric illness19 while there have been reports 
that mitochondrial DNA variation can increase or decrease risk to complex diseases, such as schizophrenia and 
Parkinson’s disease20. However, there are no replicated associations between common variation on the mitochon-
drial DNA and specific psychiatric disorders, to date19.
Y chromosome and mitochondrial DNA haplogroups could influence behavioural traits in children from 
the general population and so play a role in the observed sexual dimorphism but this has not been previously 
investigated. In our study, we derived Y chromosome and mitochondrial DNA haplogroups in children from 
the Avon Longitudinal Study of Parents and Children (ALSPAC) and tested whether haplogroups are associated 
with parent-reported behavioural traits. Findings could have implications for the role of haplogroups in sexual 
dimorphism.
Results
Y chromosome and mitochondrial DNA haplogroups were derived from children in the general population. The 
most common major Y chromosome haplogroups in ALSPAC males were R (72%) and I (19%) Y-chromosome 
haplogroups. The distribution of major Y chromosome haplogroups in ALSPAC was consistent with available 
data from England (Supplementary Figure 1). The most common major mitochondrial DNA haplogroups in 
ALSPAC were H (49%), U (13%), J (11%) and T (10%). The distribution of the major mitochondrial-DNA hap-
logroups in ALSPAC was consistent with available data from England (Supplementary Figure 1).
We investigated whether behavioural and psychiatric traits differed between males and females. The majority 
of traits showed sex differences with the exception of psychosis measured at 14 (Fig. 1); there was a higher propor-
tion of males than of females with high number of behavioural and psychiatric traits across all categories. There 
was one exception, psychotic experiences, which were more commonly reported in females. The largest difference 
was for attention/activity trait, with 38.1% of males scoring high compared to 24.5% of females (P < 0.001).
Primary analysis of major haplogroups. The primary analysis involved Y chromosome and mitochon-
drial DNA major haplogroups. Weak association was found between major Y chromosome haplogroups and a 
high or low classification of number of behavioural and psychiatric traits (Table 1) or the raw number of traits 
(Table S2).
Weak evidence was found for association between the major mitochondrial-DNA haplogroups and a high or 
low classification of number of behavioural and psychiatric traits (Table 2) or the raw number of traits (Table S3).
Secondary analysis of major haplogroup subgroups. To further investigate for potential associations, 
we considered subgroups of the major Y chromosome haplogroups R and I (Table 3) in the secondary analysis. Y 
chromosome haplogroups and subgroups were not associated with categorical (Table S4) or continuous variables 
(Table S5) of behavioural and psychiatric traits.
We considered subgroups of the larger mitochondrial-DNA haplogroups H, J, K, T and U (Table 3) in the 
secondary analysis. Weak evidence was found of association between these haplogroups and subgroups and cate-
gorical (Table S6) or continuous variables (Table S7) of behavioural and psychiatric scores.
Discussion
Research on possible factors contributing to sex differences in behavioural and psychiatric traits has been limited7 
and this is the first investigation of the association of Y chromosome and/or mitochondrial DNA haplogroups 
with behavioural and psychiatric traits in children from the general population. We report here that there were 
more males than females with higher scores on behavioural and psychiatric trait scales. However, psychotic expe-
riences were more common in females than males at two different time points. The haplogroup structure of Y 
Figure 1. Sexual dimorphism across psychiatric and behavioural traits (N>4000).
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chromosome and mitochondrial DNA in ALSPAC is consistent with a population of English origin. Y chromo-
some or mitochondrial DNA haplogroups were not associated with behavioural and psychiatric traits in ALSPAC.
There is convincing evidence that the Y chromosome is implicated in regulating differences in behaviour 
between the sexes in animal models. However, the biological mechanisms behind this are poorly understood. The 
difficulty in including the Y chromosome in GWAS is not contributing to improving understanding of the role of 
Y chromosome. The most convincing report of an association of the Y chromosome with a sexually dimorphic 
phenotype has been found in relation to coronary heart disease. In a cohort of British men haplogroup I was asso-
ciated with a 50% increase in risk of cardiovascular disease with differential expression of macrophages between 
haplogroup I and other haplogroups21.
Behavioural problems and psychiatric disorders in children and adults are highly sexually dimorphic. 
However, there are few reports of Y chromosome haplogroup investigations in psychiatric phenotypes. A pre-
vious study22 found weak evidence of an association between Y chromosome haplogroups and autism and our 
findings are consistent with this. In a study of Y chromosome haplogroups and aggression in a cohort of men 
from Pakistan, there were no differences in mean scores of aggression across the five different haplogroups cap-
tured in the study23 while there are reports of patients with Turner syndrome (XO) and Klinefelter syndrome 
(XXY) exhibiting higher rates of autism and there is weak evidence that individuals with 47, XYY syndrome have 
Odds ratios of major Y chr haplogroup on high psychiatric trait category: OR (95% C.I.) R 
haplogroup is the reference
Adjusted P valuesBehavioural/ Psychiatric trait score I Other
Attention/ Activity symptoms score (DAWBA) N = 2400 1.08 (0.88, 1.33) 1.46 (1.02, 2.09) 0.10
Awkward behaviours score (DAWBA) N = 2390 1.06 (0.86, 1.30) 1.31 (0.92, 1.86) 0.31
Troublesome behaviours score (DAWBA) N = 2396 0.98 (0.79, 1.20) 1.03 (0.72, 1.49) 0.95
SCDC N = 2397 0.98 (0.76, 1.27) 1.28 (0.84, 1.96) 0.50
Hyperactivity traits (SDQ) N = 2461 1.06 (0.86, 1.31) 1.12 (0.78, 1.62) 0.74
Conduct traits (SDQ) N = 2462 1.34 (1.10, 1.63) 1.11 (0.78, 1.56) 0.014 > 0.0061
Emotional symptoms (SDQ) N = 2462 1.05 (0.83, 1.33) 1.20 (0.81, 1.79) 0.64
Total behavioural traits (SDQ) N = 2459 1.01 (0.80, 1.27) 1.30 (0.89, 1.89) 0.41
PLIKSi age 14 N = 2062 0.89 (0.64, 1.22) 0.94 (0.53, 1.65) 0.76
PLIKSi age 18 N = 1270 0.99 (0.59, 1.67) 1.20 (0.50, 2.90) 0.92
Table 1. Odds ratios of major Y chromosome haplogroups on binary behavioural trait measures from logistic 
regression adjusted for paternal social class and GCSE results. 95% CI: 95% Confidence Interval; DAWBA: 
Development and Well-Being Assessment; SCDC: Social and communication disorders checklist; SDQ: 
Strengths and Difficulties Questionnaire; PLIKSi: Psychosis-Like Symptom Interview. 1Smallest adjusted p value 
compared to multiple testing threshold.
Odds ratios of major mitochondrial DNA haplogroup on high psychiatric trait category: OR (95% C.I.) HV 
haplogroup is the reference
Adjusted P 
values
Behavioural/ Psychiatric 
trait score J K TR U Other
Attention/ Activity symptoms 
score (DAWBA) N = 3857 1.02 (0.80, 1.29) 0.84 (0.64, 1.10) 1.04 (0.82, 1.31) 1.00 (0.80, 1.25) 0.86 (0.65, 1.15) 0.72
Awkward behaviours score 
(DAWBA) N = 3841 0.93 (0.74, 1.17) 0.92 (0.72, 1.18) 0.90 (0.72, 1.13) 0.97 (0.78, 1.20) 0.84 (0.64, 1.10) 0.79
Troublesome behaviours 
score (DAWBA) N = 3843 0.88 (0.69, 1.11) 0.99 (0.76, 1.28) 0.99 (0.79, 1.25) 1.03 (0.83, 1.27) 1.15 (0.88, 1.51) 0.74
SCDC N = 3850 0.86 (0.63, 1.16) 0.84 (0.60, 1.18) 0.86 (0.64, 1.16) 0.96 (0.73, 1.26) 0.76 (0.52, 1.09) 0.59
Hyperactivity traits (SDQ) 
N = 3926 0.89 (0.71, 1.11) 1.02 (0.80, 1.30 1.08 (0.87, 1.35) 0.93 (0.75, 1.14) 1.07 (0.82, 1.38) 0.73
Conduct traits (SDQ) 
N = 3925 1.21 (0.98, 1.50) 0.89 (0.70, 1.12) 1.02 (0.82, 1.26) 0.93 (0.76, 1.13) 0.92 (0.71, 1.18) 0.30
Emotional symptoms (SDQ)
N = 3927 1.10 (0.87, 1.38) 0.84 (0.64, 1.11) 0.92 (0.72, 1.17) 0.95 (0.76, 1.19) 0.79 (0.59, 1.06) 0.52
Total behavioural traits 
(SDQ) N = 3922 1.26 (0.98, 1.63) 1.11 (0.83, 1.47) 1.19 0.92, 1.54) 1.11 (0.87, 1.41) 0.77 (0.55, 1.08) 0.14
PLIKSi age 14  N = 3426 1.09 (0.78, 1.51) 0.88 (0.61, 1.27) 1.14 (0.84, 1.56) 0.70 (0.50, 0.98) 0.80 (0.53, 1.22) 0.19
PLIKSi age 18  N = 2369 0.95 (0.57, 1.59) 1.07 (0.64, 1.78) 1.65 (1.09, 2.50) 1.15 (0.75, 1.79) 0.47 (0.21, 1.03) 0.05 > 0.0061
Table 2. Odds ratios of major Mitochondrial DNA haplogroups on binary behavioural trait measures from 
logistic regression adjusted for maternal and paternal social classes and GCSE results. 95% CI: 95% Confidence 
Interval; DAWBA: Development and Well-Being Assessment; SCDC: Social and communication disorders 
checklist; SDQ: Strengths and Difficulties Questionnaire; PLIKSi: Psychosis-Like Symptom Interview. 1Smallest 
adjusted p value compared to multiple testing threshold.
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a higher risk of developing bipolar disorder and schizophrenia13, 15. Mitochondrial DNA has been investigated in 
relation to schizophrenia24 and bipolar disorder25 although conclusions have been limited with small sample sizes 
and inconsistent reporting26.
We investigated Y chromosome and mitochondrial DNA haplogroups in children from a sample representa-
tive of the general population. The main strength of our study was the use of a large population of children from 
a homogeneous population. The ALSPAC study participants come from a small geographic region in the South 
West of England. Only participants of European origin were included in the study as part of the quality control 
protocol of the GWAS. All of our analyses were performed within the same population and did not require a 
control group, which could have resulted in issues with population stratification due to imperfect matching of 
cases and controls. This can be an important issue in Y chromosome analysis because even populations from the 
same country can have different Y chromosome haplogroup structure. We were also able to access data on differ-
ent behavioural and psychiatric trait scales, such as the SDQ and DAWBA, which have been used extensively in 
population cohorts for research purposes.
One of the limitations of our study was the small number of individuals in some of the haplogroups. However, 
this is expected due to the rarity of certain Y chromosome haplogroups in European populations. Another limi-
tation is that the effect of genetic variation on psychiatric traits may vary at different ages and may appear during 
adolescence which we were not able to test due to the data not being available. Another challenge in the study 
was presented by the distribution of behavioural and psychiatric traits in the general population. A large number 
of individuals did not have any symptoms. Therefore, the distribution of the traits was exceedingly left skewed 
and transforming to something approaching normality was not possible. To overcome this, we dichotomized the 
variables and also performed sensitivity analyses with raw continuous scores. Also, we only investigated common 
variants and not copy-number variation or rare variants.
Although we do not report an association between the Y chromosome haplogroups and mitochondrial DNA 
haplogroups and risk of behavioural and psychiatric problems in the general population, we consider that our 
study has important implications; it highlights that if there are common variants on the Y chromosome and 
mitochondrial DNA associated with behavioural problems, they are of small effect size and would require large 
collaborative efforts to be identified. Other possible explanations for sexual dimorphism in psychiatric traits are 
gene-environment interactions27 and gene-sex interactions which were not investigated in this study.
Given that the DNA markers on the Y chromosome and mitochondrial DNA are available on most GWAS 
chips but have not been largely utilised, such a collaborative effort would involve extracting relevant data 
from multiple studies rather than new genotyping efforts and could be an important step in understanding 
non-autosomal variation. Collaboration would be even more important for the Y chromosome because only half 
of any genotyped sample is usually male and can be used for analysis.
Y chromosome Mitochondrial DNA
Haplogroup Count (%) Haplogroup Count (%)
R 3452 (72.1) H 4109 (49.9)
R1a1 210 (4.4) H1 1592 (19.4)
R1b1 328 (6.9) H2 826 (10.0)
R1b1b2 1528 (31.9) H3 387 (4.7)
R1b1b2g 1061 (22.2) H4 168 (2.0)
R1b1b2h 296 (6.2) H5 252 (3.1)
Q and other R 29 (0.6) H6 235 (2.9)
IJ 1039 (21.7) Other HV 649 (7.8)
I1 460 (9.6) J 885 (10.8)
I2 150 (3.1) J1 717 (8.7)
I2b 228 (4.8) J2 168 (2.1)
Other I 71 (1.5) K 706 (8.6)
J 130 (2.7) K1 569 (6.9)
Other 297 (6.2) Other K 137 (1.7)
E 143 (3.0) T 845 (10.3)
CFGH 110 (2.3) T2 668 (8.1)
LTNO 44 (0.9) Other TR 177 (2.2)
U 1084 (13.2)
U4 165 (2.0)
U5 722 (8.8)
Other U 197 (2.4)
Other 591 (7.2)
M (M, C, D, L) 67 (0.8)
N (N, A, I, W, X) 524 (6.4)
Total: 4788 Total: 8220
Table 3. Major haplogroups and subgroups.
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Methods
Study Participants. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective birth 
cohort which recruited pregnant women with expected delivery dates between April 1991 and December 1992 
from Bristol UK. 14,541 pregnant women were initially enrolled with 14,062 children born. Detailed information 
on health and development of children and their parents were collected from regular clinic visits and completion 
of questionnaires. A detailed description of the cohort has been published previously28, 29. The study website 
contains details of all the data that is available through a fully searchable data dictionary: http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/. The study was carried out in accordance with the ethical stand-
ards of the Helsinki Declaration and ethical approval was obtained from the ALSPAC Law and Ethics Committee 
and the Local Ethics Committees. Informed consent was obtained from all subjects.
Genetic measures. ALSPAC genotyping. A total of 9,912 participants were genotyped using the Illumina 
HumanHap550 quad genome-wide SNP genotyping platform by Sample Logistics and Genotyping Facilities at 
the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 
23andMe. PLINK software (v1.07) was used to carry out quality control (QC) measures30. After QC, 8,365 unre-
lated individuals were available for analysis. Information on QC performed is contained in the Supplementary 
Methods.
Y chromosome. For Y-DNA haplogroup determination, the Y-chromosomal SNPs of all 5,085 male participants 
in the dataset were used. The pseudo-autosomal SNPs (coded as chromosome 25) were removed from the anal-
ysis using the PLINK software package30. The resulting Y chromosomal genotypes (816 SNPs) of each individual 
were then piped in to the Y-Fitter (v0.2) software (maps genotype data to the Y-DNA phylogenetic tree built by 
Karafet et al.31, available online at sourceforge.net/projects/yfitter) and their respective Y-DNA haplogroup was 
determined. After removal of individuals with ‘False’ haplogroup determinations (i.e. ones which did not have 
enough SNPs to reliably determine haplogroup), we were left with 5,080 individuals. Remaining individuals with 
a haplogroup result which began with the letter R (e.g. R1b1) were clustered in to a single group named ‘Clade R’ 
and likewise the same was done with the haplogroups beginning with the other letters. Major haplogroups were 
defined as containing multiple haplogroups that are closely related to utilize information on less common hap-
logroups. After QC our data-set contained 4,788 males with derived Y chromosome haplogroups.
Mitochondrial DNA. 7,554 custom mitochondrial probes, targeting 2,824 unique mtDNA positions, were 
included on the Illumina HumanHap550 quad genome-wide SNP genotyping platform. A total of 1062 probes 
passed QC for the batch that was genotyped by Laboratory Corporation of America (n = 7590), whilst 629 probes 
passed QC for the batch genotyped by the Sanger Institute (n = 775). Haplogroup assignment was performed as 
described by Kloss-Brandstatter et al.32, and samples with a quality score of more than 90% were used for our 
analysis. Major haplogroups were defined as containing multiple haplogroups that are closely related to utilize 
information on less common haplogroups. After QC and removing individuals with withdrawn consent; our 
data-set contained 4,211 males and 4,009 females with derived mitochondrial DNA haplogroups. More infor-
mation on how the mitochondrial DNA haplogroups were derived is contained in the Supplementary Methods.
Behavioural measures. Strengths and Difficulties Questionnaire. The Strengths and Difficulties 
Questionnaire (SDQ) is a behavioural screening questionnaire with high reliability and validity which includes 
questions on five domains: emotional symptoms, conduct problems, hyperactivity symptoms, peer relationship 
problems and prosocial behaviours ranging from 0 to 10 each33. A total difficulties score can be obtained by sum-
ming the following subscales: emotional symptoms, conduct problems, hyperactivity score and peer relationship 
problems (not including prosocial behaviour for which a higher score indicates less behavioural problems). SDQ 
total difficulties score ranges from 0 to 40 (www.sdqinfo.com). Mother’s reports on their children’s behavioural 
problems were obtained at 7 years of age to maximise the number of individuals available for analysis. Cut-offs 
were used to dichotomise each of the five SDQ subscales as well as total difficulties score according to previous 
studies.
Development and Well-Being Assessment. The Development and Well-Being Assessment (DAWBA) is a 
semi-structured interview used to diagnose psychiatric disorders in children34 and calculate the number of 
psychiatric disorder traits. Attention-Deficit/Hyperactivity Disorder (ADHD), Oppositional/Defiant Disorder 
(ODD) and Conduct Disorder (CD) traits were assessed in ALSPAC when the participants were aged 7 years and 
7 months old using the parent-completed DAWBA attention/activity symptoms score, awkward behaviours score 
and troublesome behaviours score respectively. For each item, parents marked boxes to say whether their child 
showed the behaviour; these were coded 0 for “no,” 1 for “a little more than others”, and 2 for “a lot more than 
others.” A total trait score was calculated by summing these responses. Scores on measures with <30% missing 
items were mean imputed.
Skuse social cognition score. The Skuse social cognition scale (SCDC)35 is designed to summarise the main 
features of the social cognition behaviour of individuals and was employed to assess autistic traits in children 
from ALSPAC. This was in the form of a parent-completed screening questionnaire on the child at 7 years and 7 
months.
Psychosis-Like Symptom Interview. The semi-structured Psychosis-Like Symptom Interview (PLIKSi)36, 37, which 
draws on principles of standardized clinical examination developed for the Schedule for Clinical Assessment in 
www.nature.com/scientificreports/
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Neuropsychiatry (SCAN), was used to assess psychotic experiences at ages 12 and 18 years. The PLIKSi allows 
rating of 12 psychotic experiences including hallucinations (visual and auditory), delusions (spied on, persecu-
tion, thoughts read, reference, control, grandiosity, other) and experiences of thought interference (broadcasting, 
insertion and withdrawal). The interviewers were psychology graduates trained in assessment using the SCAN 
psychosis section and using the PLIKSi. Psychotic experiences were rated as not present, suspected or definitely 
psychotic. Unclear responses were always ‘rated down’ and symptoms were rated as definite only when a clear 
example was provided. Individuals were deemed as having a psychotic experience if rated as having 1 or more 
definite or suspected psychotic experience compared to no psychotic experiences.
Statistical Analysis. Most of the continuous variables were heavily zero-skewed; the majority of partici-
pants scored zero. We used categorical variables as appropriate normalisation was not possible in the majority of 
cases. Cut-offs were used to dichotomise each of the variables according to previous studies and the distribution 
of the variables33. The attention/activity symptoms score and SCDC were stratified into (≤5 & >5), the awkward 
behaviours score, troublesome behaviours score and two PLIKS measures were stratified into (≤0 & > 0), the 
hyperactivity traits score and emotional symptoms score were stratified into (≤2 & >2), the conduct traits score 
was stratified into (≤1 & >1) and the total behavioural score was stratified into (≤10 & >10). Analysis on both 
categorical and continuous variables are presented for comparison.
Chi squared tests were used to test for sex differences in categorical variables with linear regression used for con-
tinuous variables. Chi squared tests were used to test for associations between haplogroups and categorical variables 
with logistic regression employed when confounders were included. As a sensitivity analysis, multiple regression 
was used to test for association between haplogroups and the original continuous variables whilst adjusting for con-
founders. The tetrachoric correlation between the binary variables was computed to determine if the variables were 
independent with a 0.8 cut-off. The Bonferroni-Holm method was used to adjust the number of independent varia-
bles for multiple testing38. No pairwise correlation exceeded the threshold of 0.8 therefore the variables were treated 
as independent (Table S1) and multiple testing correlation was performed assuming 10 independent variables.
The pattern of inheritance means that individuals with different haplogroups may differ phenotypically, spe-
cifically in terms of social class and outcomes associated with it, such as education. The most appropriate variables 
to gauge social class of a child would be the social class and the educational level of the parents. General certificate 
of secondary education (GCSE) results were used as a measure of a child’s cognitive abilities. The Y chromo-
some is inherited from the father; therefore paternal social class was included in the Y chromosome analysis. 
Mitochondrial DNA is inherited from the mother; thus maternal social class was included in the analysis along 
with paternal social class for mitochondrial DNA. Y chromosome analysis was only performed on male partici-
pants while male and female participants were included in mitochondrial DNA analysis.
Initially just the major haplogroups e.g. “R” and “I” for the Y chromosome and “H” and “U” for the mito-
chondrial DNA were analysed but subsequent analysis investigated subgroups of these major haplogroups. 
Subgroups were investigated if their frequency was >2%. Y chromosome and mitochondrial DNA haplogroups 
were grouped together using online phylogenetic trees39, 40.
Pie-charts were created using ALSPAC haplogroup data as well as haplogroup data for England from Eupedia 
(www.eupedia.com) and STATA 13 was used for all data analysis.
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